Success Metrics

Clinical Success Rate

75.0%

Based on 3 completed trials

Completion Rate

75%(3/4)

Active Trials

0(0%)

Results Posted

0%(0 trials)

Terminated

1(25%)

Phase Distribution

Ph not_applicable

25%

Ph phase_2

25%

Ph phase_4

25%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution3 total trials

Phase 2Efficacy & side effects

1(33.3%)

Phase 4Post-market surveillance

1(33.3%)

N/ANon-phased studies

1(33.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(3)

Terminated(1)

Detailed Status

Completed3

Terminated1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

75.0%

Most Advanced

Phase 4

Trials by Phase

Phase 21 (33.3%)

Phase 41 (33.3%)

N/A1 (33.3%)

Trials by Status

terminated125%

completed375%

Recent Activity

0 active trials

Showing 4 of 4

completed

DSE vs. FFR in SCAD and BYSTANDER Lesions

NCT03383718

completednot_applicable

Recovery of Left Ventricular Function in Chronic Total Occluded Coronary Arteries

NCT01924962

completedphase_4

Comparison of Two Dental Techniques Used to Treat Teeth Which Have Become Infected or Painful Following Trauma

NCT01817413

terminatedphase_2

Treatment With Autologous Skeletal Myoblasts

NCT00975234

Clinical Trials (4)

Showing 4 of 4 trials

NCT03383718

DSE vs. FFR in SCAD and BYSTANDER Lesions

Completed

NCT01924962Not Applicable

Recovery of Left Ventricular Function in Chronic Total Occluded Coronary Arteries

Completed

NCT01817413Phase 4

Comparison of Two Dental Techniques Used to Treat Teeth Which Have Become Infected or Painful Following Trauma

Completed

NCT00975234Phase 2

Treatment With Autologous Skeletal Myoblasts

Terminated

All 4 trials loaded

Drug Details

Intervention Type: PROCEDURE
Total Trials: 4